Found 5 matching trials
Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
PHASE1It is a single-center, open-labeled, single-arm, non-randomized investigato...
Location
Institute of Hematology & Blood Diseases Hospital
To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma
EARLY_PHASE1To evaluate the safety and tolerability of anti-GPRC5D-CD19 CAR-T cells inf...
Location
Guangdong Second Provincial General Hospital
BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma
EARLY_PHASE1This study is a single-arm, multicenter clinical trial of dose escalation a...
Location
Multiple Locations
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
PHASE1An open label, dose exploratory clinical study to evaluate the safety, effi...
Location
The First Affiliated Hospital College of Medicine Zhejiang University
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
PHASE1This is a single-center, open clinical study, divided into two phases of do...
Location
Multiple Locations